Backed on pure business model, Aashish Tater, head of research at Fort Share Broking picks Arshiya International and Indraprastha Medical. He recommends a buy on dips from a long term perspective, for both stocks, looking forward at the potential of the innovative business structure.
"I am bullish on logistics business, and Arshiya International has a potential of the business model and single digit PE multiple, it is a safe bet, a quality stock wit return of 10-25% for three years," he says. Tater says the booming medical tourism business is going to benefit Indraprasth Medical. The company's impending concept of 'mini hospitals' to treat emergency patients operated at parent company. Apollo Hospitals, Tater says can be the next big thing. "If one puts in their money in this stock, within a period of 2-2.5 years it can double up," he added. Below is an edited transcript of Aashish Tater's comments. Also watch the accompanying video. On Arshiya International Arshiya International is not a buy at the present Rs 120-125 mark but it is a buy somewhere around Rs 105. Taking a call from business perspective, in terms of price at Rs 105 it would be available at the market cap of Rs 640-650 odd crore. It is into a business called logistics and we have been bullish on it for quite some time now. If I take a call on Arshiya at around Rs 105, it will do a net profit close to Rs 84 crore though the management pointed out Rs 90 crore. We have taken an interest impact of Rs 6 crore because of rising interest rate. On Rs 84 crore and a market cap of Rs 650 crore it is available at a PE of 8 times. This is going to be a cash cow for the companyDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!